Tab. 8.
Marketed three-lipid excipient formulations
Marketed formulation | API | Dosage form | Manufacturer | Country of sale |
---|---|---|---|---|
Agenarase® | Amprenavir | Capsule (soft gelatin) | GlaxoSmithKline | USA |
Targretin® | Bexarotene | Capsule (soft gelatin) | Ligand Pharmaceuticals Incorporated | USA |
Norvir® | Ritonavir | Capsule (soft gelatin) | Abbott Laboratories | USA |